MedTrace Logo

Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis

NCT03664596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-02-05

No results posted yet for this study

Summary

This study evaluates the dietary and therapeutic effect of supplement consisting of sublimated mare milk among patients with non-alcoholic steatohepatitis.

Conditions

  • Non-alcoholic Steatohepatitis

Interventions

DIETARY_SUPPLEMENT

Sublimated mare's milk

Supplement obtained through sublimation of mare milk, packed into one-dosage sachet (20g), and dissolved in a warm water (36 degrees of Celcius).

DRUG

Ursodeoxycholic Acid

Ursodeoxycholic acid in the form of 250 mg capsule.

Sponsors & Collaborators

  • Eurasia Invest Ltd.

    collaborator INDUSTRY

  • Ministry of Education and Science, Republic of Kazakhstan

    collaborator OTHER_GOV

  • Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-09-01
Completion
2020-12-01

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664596 on ClinicalTrials.gov